MARKET REPORT: Novacyt in demand as it battles new Covid strains

MARKET REPORT: Novacyt in demand after it launches products that can detect new variants of the Covid virus By Francesca Washtell For The Daily Mail Published: 22:53 GMT, 2 February 2021 | Updated: 22:53 GMT, 2 February 2021 Novacyt proved it is still a fast mover in the battle to beat Covid after launching products … Read more

Covid test maker Novacyt saw sales rise 20-fold last year

Covid test maker Novacyt saw sales rise 20-fold during the pandemic prompting its share price to rise 5,000% in a year Annual profits expected to jump from £1.6m to £91.8m in fresh results AIM-listed group’s share price has rocketed, but closed down 17% on Friday  By City & Finance Reporter for the Daily Mail and … Read more

MARKET REPORT: Novacyt sales up tenfold amid battle to beat Covid

Being a fast mover in the battle to beat Covid has paid off for Novacyt, a biotechnology tiddler listed on AIM that few retail investors had heard of at the start of the year. Things have changed dramatically since then, after the French group’s Southampton-based subsidiary, Primerdesign, developed one of the world’s first coronavirus tests … Read more